GlobeNewswire Inc | Jul 15, 2021 04:02PM EDT

July 15, 2021

SAN DIEGO, July 15, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.(NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer, today announced that the Company will host a conference call and live audio webcast onWednesday, August 4, 2021at5:00 p.m. ETto report its second quarter 2021 financial results and provide a corporate update.

In order to participate in the conference call, please dial 800-773-2954 (toll free) or 847-413-3731 (toll) and refer to confirmation number 50196101. The live webcast can be accessed under "Events & Presentations" in the Investors section of the Company's website atwww.fatetherapeutics.com. The archived webcast will be available on the Company's website beginning approximately two hours after the event.

AboutFate Therapeutics, Inc.Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first-in-class cellular immunotherapies for patients with cancer. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Companys immuno-oncology pipeline includes off-the-shelf, iPSC-derived natural killer (NK) cell and T-cell product candidates, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens using chimeric antigen receptors (CARs). Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Contact:Christina TartagliaStern Investor Relations, Inc.212.362.1200christina@sternir.com